This episode of the Long COVID Clinical Podcast, hosted by Drs. Anita Chopra, Andrew Schamess, and Aaron Friedberg, features Dr. Hector Bonilla, an infectious disease specialist from Stanford University School of Medicine. The discussion centers on the innovative use of repurposed medications like low-dose naltrexone and Abilify in treating long COVID and ME/CFS. Dr. Bonilla shares insights into the overlap between these conditions, highlighting symptoms such as fatigue and brain fog, and explores how these symptoms can be managed with off-label therapies. He explains the science behind targeting immune pathways and the potential of these drugs to reduce inflammation and improve patient outcomes. The episode also covers Dr. Bonilla’s clinical trials, dosing protocols, and the promising results seen in patients. It concludes with practical strategies for clinicians and patients, emphasizing the importance of evidence-based approaches in managing chronic illness.

Edited and Produced by Christopher Chiu and Carissa Lee

This episode of the Pediatric Long COVID Podcast, hosted by Drs. Anita Chopra and Andrew Schamess, features Dr. Laura Malone, Director of the Pediatric Post-COVID-19 Rehabilitation Clinic at the Kennedy Krieger Institute. The discussion centers on the unique manifestations of long COVID in children, highlighting differences in symptoms compared to adults, such as neurological and gastrointestinal issues. Dr. Malone elaborates on the diagnostic challenges faced when children lack confirmed prior COVID infection and emphasizes the importance of a multidisciplinary approach involving neurologists, rehabilitation specialists, and mental health professionals. She also explores the current prognosis for pediatric patients, the role of emerging research in understanding physiological differences, and the success of the Pediatric Long COVID ECHO telementoring program. The episode concludes with insights into reducing stigma around post-viral syndromes in children and the ongoing need for research and education in this evolving field.

Edited and Produced by Christopher Chiu and Carissa Lee

This episode of the Long COVID Clinical Podcast, hosted by Drs. Anita Chopra and Andrew Schamess, delves into the phases of COVID-19 infection, underlying mechanisms, diagnostic biomarkers, and novel therapeutics with Dr. Daniel Griffin, a renowned infectious disease specialist and host of the "This Week in Virology " podcast. The discussion covers the progression and diagnosis of long COVID, pathobiology theories, and the involvement of the autonomic nervous system and small fiber neuropathy. Dr. Griffin highlights practical biomarkers for clinical use and discusses both non-pharmacological and pharmacological treatment strategies. The conversation also addresses the impact of funding changes on research progress and future directions for managing long COVID. The episode concludes with a hopeful outlook on collaborative efforts to advance understanding and improve patient care in the face of long COVID challenges.

Edited and Produced by Christopher Chiu and Carissa Lee